Author

V. Santos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

H. Peinado· 2 shared A. Benguria· 1 shared A. Di Giannatale· 1 shared A. Dopazo· 1 shared A. Efeyan· 1 shared A. Hernandez-Barranco· 1 shared A. Ortega-Molina· 1 shared C. Blanco· 1 shared

Activity by Year

2023-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

H. Peinado

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

NGFR regulates germinal center B-cell activation and negative selection

A. Hernandez-Barranco, M. S. Mazariegos, V. Santos, E. Caleiras, L. Nogues, F. Mourcin, S. Leonard, C. Oblet, S. Genebrier, D. Rossille, A. Benguria, E. Vazquez, A. Dopazo, A. Efeyan, A. Ortega-Molina, , H. Peinado

This study shows that NGFR regulates germinal center B-cell activation and negative selection by maintaining GC structure and function, affecting antibody production and immune tolerance.

bioRxiv · Jul 14, 2023 · PreprintImmunology

Endoglin, a novel biomarker and therapeutical target to prevent malignant peripheral nerve sheath tumor growth and metastasis

T. Gonzalez-Munoz, A. Di Giannatale, S. Garcia-Silva, V. Santos, S. Sanchez-Redondo, C. Savini, O. Grana-Castro, C. Blanco, D. J. Pisapia, J. L. Peralto, C. Romagosa Perez-Portabella, R. Alaggio, M. S. Benassi, L. Pazzaglia, K. Scotlandi, , H. Peinado

This study identifies endoglin (ENG) as a biomarker and therapeutic target for MPNSTs, showing that targeting ENG with antibodies or combining it with MEK inhibitors reduces tumor growth and metastasis.

Clinical Cancer Research · Jul 11, 2023Peer-reviewedCancer Biology